MillikenS.P., MatzeG.R., KeaneW.F.Anti-microbial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.Perit Dial Int1991; 11: 252–60.
3.
Report of a Working Party of the British Society for Anti-microbial Chemotherapy.Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis.Lancet1987; 1: 845–8.
4.
BeamanM., SolaroL., McGonigleR.J.S., MichaelJ., AduD.Vancomycin and ceftazidime in the treatment of CAPD peritonitis.Nephron1989; 51: 51–5.
5.
GrayH.H., GouldingS., EykynS.J.Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.Clin Nephrol1985; 23: 81–4.
PancorboS., ComtyC.Peritoneal transport of vancomycin in four patients undergoing continuous ambulatory peritoneal dialysis.Nephron1982; 31: 37–9.
8.
BastaniB., SpykerD.A., WestervelyF.B.Peritoneal absorption of vancomycin during and after resolution of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients.Perit Dial Int1988; 8: 135–6.
9.
BastaniB., FreerK., ReadD.Treatment of gram positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.Nephron1987; 45: 283–5.
